
QDEL Valuation
QuidelOrtho Corp
- Overview
- Forecast
- Valuation
- Earnings
QDEL Relative Valuation
QDEL's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, QDEL is overvalued; if below, it's undervalued.
Historical Valuation
QuidelOrtho Corp (QDEL) is now in the Undervalued zone, suggesting that its current forward PE ratio of 10.41 is considered Undervalued compared with the five-year average of 15.60. The fair price of QuidelOrtho Corp (QDEL) is between 59.51 to 87.65 according to relative valuation methord. Compared to the current price of 28.69 USD , QuidelOrtho Corp is Undervalued By 51.79%.
Relative Value
Fair Zone
59.51-87.65
Current Price:28.69
51.79%
Undervalued
10.41
PE
1Y
3Y
5Y
Trailing
Forward
7.32
EV/EBITDA
QuidelOrtho Corp. (QDEL) has a current EV/EBITDA of 7.32. The 5-year average EV/EBITDA is 8.23. The thresholds are as follows: Strongly Undervalued below 3.00, Undervalued between 3.00 and 5.62, Fairly Valued between 10.85 and 5.62, Overvalued between 10.85 and 13.47, and Strongly Overvalued above 13.47. The current Forward EV/EBITDA of 7.32 falls within the Historic Trend Line -Fairly Valued range.
11.09
EV/EBIT
QuidelOrtho Corp. (QDEL) has a current EV/EBIT of 11.09. The 5-year average EV/EBIT is 13.22. The thresholds are as follows: Strongly Undervalued below 3.82, Undervalued between 3.82 and 8.52, Fairly Valued between 17.91 and 8.52, Overvalued between 17.91 and 22.61, and Strongly Overvalued above 22.61. The current Forward EV/EBIT of 11.09 falls within the Historic Trend Line -Fairly Valued range.
0.71
PS
QuidelOrtho Corp. (QDEL) has a current PS of 0.71. The 5-year average PS is 2.35. The thresholds are as follows: Strongly Undervalued below -1.03, Undervalued between -1.03 and 0.66, Fairly Valued between 4.04 and 0.66, Overvalued between 4.04 and 5.73, and Strongly Overvalued above 5.73. The current Forward PS of 0.71 falls within the Historic Trend Line -Fairly Valued range.
5.32
P/OCF
QuidelOrtho Corp. (QDEL) has a current P/OCF of 5.32. The 5-year average P/OCF is 9.09. The thresholds are as follows: Strongly Undervalued below -6.06, Undervalued between -6.06 and 1.51, Fairly Valued between 16.67 and 1.51, Overvalued between 16.67 and 24.24, and Strongly Overvalued above 24.24. The current Forward P/OCF of 5.32 falls within the Historic Trend Line -Fairly Valued range.
4.60
P/FCF
QuidelOrtho Corp. (QDEL) has a current P/FCF of 4.60. The 5-year average P/FCF is 9.09. The thresholds are as follows: Strongly Undervalued below -0.19, Undervalued between -0.19 and 4.45, Fairly Valued between 13.73 and 4.45, Overvalued between 13.73 and 18.36, and Strongly Overvalued above 18.36. The current Forward P/FCF of 4.60 falls within the Historic Trend Line -Fairly Valued range.
QuidelOrtho Corp (QDEL) has a current Price-to-Book (P/B) ratio of 0.70. Compared to its 3-year average P/B ratio of 0.93 , the current P/B ratio is approximately -25.31% higher. Relative to its 5-year average P/B ratio of 2.41, the current P/B ratio is about -71.15% higher. QuidelOrtho Corp (QDEL) has a Forward Free Cash Flow (FCF) yield of approximately 0.67%. Compared to its 3-year average FCF yield of 2.41%, the current FCF yield is approximately -72.27% lower. Relative to its 5-year average FCF yield of 5.80% , the current FCF yield is about -88.49% lower.
0.70
P/B
Median3y
0.93
Median5y
2.41
0.67
FCF Yield
Median3y
2.41
Median5y
5.80
Competitors Valuation Multiple
The average P/S ratio for QDEL's competitors is 2.91, providing a benchmark for relative valuation. QuidelOrtho Corp Corp (QDEL) exhibits a P/S ratio of 0.71, which is -75.70% above the industry average. Given its robust revenue growth of -3.63%, this premium appears unsustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of QDEL decreased by 37.08% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -23.19 to -41.60.
The secondary factor is the Revenue Growth, contributed -3.63%to the performance.
Overall, the performance of QDEL in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch

ALHC
Alignment Healthcare Inc
16.360
USD
+0.25%

MLTX
MoonLake Immunotherapeutics
55.750
USD
+1.73%

OSIS
OSI Systems Inc
230.050
USD
+0.41%

PAR
PAR Technology Corp
51.180
USD
-2.38%

JJSF
J&J Snack Foods Corp
111.570
USD
-0.08%

NSA
National Storage Affiliates Trust
32.230
USD
+0.91%

MAN
ManpowerGroup Inc
42.400
USD
+2.64%

NOMD
Nomad Foods Ltd
15.540
USD
+0.97%

CPRI
Capri Holdings Ltd
20.590
USD
-4.54%

AG
First Majestic Silver Corp
9.140
USD
+2.01%
FAQ

Is QuidelOrtho Corp (QDEL) currently overvalued or undervalued?
QuidelOrtho Corp (QDEL) is now in the Undervalued zone, suggesting that its current forward PE ratio of 10.41 is considered Undervalued compared with the five-year average of 15.60. The fair price of QuidelOrtho Corp (QDEL) is between 59.51 to 87.65 according to relative valuation methord. Compared to the current price of 28.69 USD , QuidelOrtho Corp is Undervalued By 51.79% .

What is QuidelOrtho Corp (QDEL) fair value?

How does QDEL's valuation metrics compare to the industry average?

What is the current P/B ratio for QuidelOrtho Corp (QDEL) as of Sep 01 2025?

What is the current FCF Yield for QuidelOrtho Corp (QDEL) as of Sep 01 2025?

What is the current Forward P/E ratio for QuidelOrtho Corp (QDEL) as of Sep 01 2025?
